GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity. Acorda Therapeutics had submitted an IND
Arzerra is indicated for the treatment of chronic lymphocytic leukaemia (CLL) in patients who are refractory to fludarabine and alemtuzumab. GSK claimed that Arzerra is a new monoclonal
Bionovo’s US Patent No 7,700,136 also covers the use of its proprietary Bezielle formulation as a monotherapy for the treatment of breast cancer. The patent is expected to
The patented technology converts thin-layer chromatography (TLC) compound retention data into a linear gradient and also provides the user with sample loading estimates for any Biotage flash cartridge.
The Advia Chemistry Ecstasy assay allows the choice of two cut-off values (300ng/ml and 500ng/ml), complying with both the latest Samhsa1 recommendations as well as EWDTS2 guidelines. The
The Genous Bio-engineered Cobalt Chromium Stent combines OrbusNeich’s patented endothelial progenitor cell (EPC) capture technology Genous with a L605 cobalt chromium bare metal stent based on the company’s
The recommendation was made following discussions with Cell Therapeutics about the preclinical and clinical Pixantrone data, including PIX301, and the desire to explore the potential benefits pixantrone may
IOBS are a relatively new classification of pathogen detection equipment that use advanced fiber optic-based technology to detect a wide variety of human and animal pathogens. These devices
As per the collaboration, which was signed on March 2008, the companies will leverage a number of Silence’s proprietary lipid delivery and targeting technologies to develop new delivery
Metoprolol Tartrate is the sixth product being launched under the Strides and Sagent Pharmaceuticals partnership. Metoprolol is the generic equivalent of Novartis pharmaceutical’s Lopressor (Metoprolol Tartarate injection, USP).
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.